Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Autor: Barretina J; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Caponigro G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Stransky N; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Venkatesan K; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Margolin AA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.; Sage Bionetworks, 1100 Fairview Ave. N., Seattle, Washington, 98109, USA., Kim S; Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA., Wilson CJ; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Lehár J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Kryukov GV; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Sonkin D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Reddy A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Liu M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Murray L; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Berger MF; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA., Monahan JE; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Morais P; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Meltzer J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Korejwa A; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Jané-Valbuena J; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA., Mapa FA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Thibault J; Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA., Bric-Furlong E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Raman P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Shipway A; Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA., Engels IH; Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA., Cheng J; Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA., Yu GK; Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA., Yu J; Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA., Aspesi P Jr; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., de Silva M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Jagtap K; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Jones MD; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Wang L; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Hatton C; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA., Palescandolo E; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA., Gupta S; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Mahan S; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Sougnez C; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Onofrio RC; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Liefeld T; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., MacConaill L; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA., Winckler W; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Reich M; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Li N; Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA., Mesirov JP; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Gabriel SB; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Getz G; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Ardlie K; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA., Chan V; Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA., Myer VE; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Weber BL; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Porter J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Warmuth M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Finan P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Harris JL; Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA., Meyerson M; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA., Golub TR; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland, 20815, USA., Morrissey MP; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Sellers WR; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA., Schlegel R; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA. robert.schlegel@novartis.com., Garraway LA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA. Levi_Garraway@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.
Jazyk: angličtina
Zdroj: Nature [Nature] 2019 Jan; Vol. 565 (7738), pp. E5-E6.
DOI: 10.1038/s41586-018-0722-x
Databáze: MEDLINE